Home › Funds › COMGEST GLOBAL INVESTORS S.A.S. › JNJ

COMGEST GLOBAL INVESTORS S.A.S. position in JNJ

JOHNSON & JOHNSON · Health Care

COMGEST GLOBAL INVESTORS S.A.S. reported holding 904,805 shares of JNJ (JOHNSON & JOHNSON) in its Q3 2026 13F filing — a position valued at US$239.5M, representing 5.54% of its reported portfolio and ranking #7 among its reported holdings. COMGEST GLOBAL INVESTORS S.A.S. has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)904.80K sh
Reported value held$239.54M
Portfolio Weight5.54%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How COMGEST GLOBAL INVESTORS S.A.S.'s JNJ position evolved

COMGEST GLOBAL INVESTORS S.A.S. first disclosed a stake in JNJ in Q3 2023 at 1,811,029 shares (US$282.1M). The position peaked in Q1 2025 at 2,158,820 shares, worth US$358.0M. Across 13 filings, COMGEST GLOBAL INVESTORS S.A.S. increased the stake 4 time(s), trimmed it 6 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 904,805 shares valued at US$239.5M — a reduction of -384,723 shares quarter over quarter.. Notable position changes include a 30% trim in Q3 2026 (shares rose 6% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 1.81M $282.07M New
Q4 2023 1.82M $284.74M Hold
Q1 2024 1.86M $294.36M Add
Q2 2024 1.99M $290.56M Add
Q3 2024 2.10M $339.87M Add
Q4 2024 2.10M $303.83M Hold
Q1 2025 2.16M $358.02M Add
Q2 2025 2.07M $316.15M Reduce
Q3 2025 1.82M $337.22M Reduce
Q4 2025 1.65M $342.28M Reduce
Q1 2026 1.34M $328.58M Reduce
Q2 2026 1.29M $327.50M Reduce
Q3 2026 904.80K $239.54M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About JNJ and 13F data

JNJ (JOHNSON & JOHNSON) is a Health Care company. 32 other funds we track also report a position in JNJ — the largest reported positions include BlackRock Inc (US$53.87B), Vanguard Group (US$49.74B), VANGUARD CAPITAL MANAGEMENT LLC (US$41.76B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding JNJ

All JNJ fund holders →

FAQ

How long has COMGEST GLOBAL INVESTORS S.A.S. held JNJ?

COMGEST GLOBAL INVESTORS S.A.S. has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is COMGEST GLOBAL INVESTORS S.A.S.'s current position in JNJ?

As of Q3 2026, COMGEST GLOBAL INVESTORS S.A.S. holds 904.80K shares of JNJ (JOHNSON & JOHNSON), valued at $239.54M, representing 5.54% of its reported portfolio and ranking #7.

Has COMGEST GLOBAL INVESTORS S.A.S. been buying or selling JNJ?

In the latest 13F filing (Q3 2026), COMGEST GLOBAL INVESTORS S.A.S. reduced its position in JNJ. The position peaked in Q1 2025 at 2.16M shares.

Which other funds hold JNJ?

Other major institutional holders of JNJ include BlackRock Inc, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 32 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.